메뉴 건너뛰기




Volumn 13, Issue 2, 2013, Pages 156-158

Resistance to trastuzumab in HER2-positive mucinous invasive ductal breast carcinoma

Author keywords

Hormone receptor; Invasive breast cancer; Mucins

Indexed keywords

ANASTROZOLE; BEVACIZUMAB; CAPECITABINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GEMCITABINE; GOSERELIN; LAPATINIB; PACLITAXEL; TAMOXIFEN; TRASTUZUMAB; ZOLEDRONIC ACID;

EID: 84875152963     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2012.11.007     Document Type: Article
Times cited : (15)

References (17)
  • 1
    • 73349085919 scopus 로고    scopus 로고
    • Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer
    • N.L. Spector, K.L. Blackwell Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer J Clin Oncol 27 2009 5838 5847
    • (2009) J Clin Oncol , vol.27 , pp. 5838-5847
    • Spector, N.L.1    Blackwell, K.L.2
  • 2
    • 0030951481 scopus 로고    scopus 로고
    • The importance of histologic type on breast cancer survival
    • M.E. Northridge, G.G. Rhoads, D. Wartenberg The importance of histologic type on breast cancer survival J Clin Epidemiol 50 1997 283 290
    • (1997) J Clin Epidemiol , vol.50 , pp. 283-290
    • Northridge, M.E.1    Rhoads, G.G.2    Wartenberg, D.3
  • 3
    • 71049185479 scopus 로고    scopus 로고
    • Breast carcinoma - Rare types: Review of the literature
    • R. Yerushalmi, M.M. Hayes, K.A. Gelmon Breast carcinoma - rare types: review of the literature Ann Oncol 20 2009 1763 1770
    • (2009) Ann Oncol , vol.20 , pp. 1763-1770
    • Yerushalmi, R.1    Hayes, M.M.2    Gelmon, K.A.3
  • 4
    • 38449089721 scopus 로고    scopus 로고
    • Mucinous breast lesions: Diagnostic challenges
    • P.H. Tan, G.M. Tse, B.H. Bay Mucinous breast lesions: diagnostic challenges J Clin Pathol 61 2008 11 19
    • (2008) J Clin Pathol , vol.61 , pp. 11-19
    • Tan, P.H.1    Tse, G.M.2    Bay, B.H.3
  • 5
    • 51649096934 scopus 로고    scopus 로고
    • A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma
    • S. Di Saverio, J. Gutierrez, E. Avisar A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma Breast Cancer Res Treat 111 2008 541 547
    • (2008) Breast Cancer Res Treat , vol.111 , pp. 541-547
    • Di Saverio, S.1    Gutierrez, J.2    Avisar, E.3
  • 6
    • 52049107847 scopus 로고    scopus 로고
    • Mucinous breast carcinoma: A large contemporary series
    • C.R. Barkley, J.A. Ligibel, J.S. Wong Mucinous breast carcinoma: a large contemporary series Am J Surg 196 2008 549 551
    • (2008) Am J Surg , vol.196 , pp. 549-551
    • Barkley, C.R.1    Ligibel, J.A.2    Wong, J.S.3
  • 7
    • 0032895974 scopus 로고    scopus 로고
    • Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas
    • S.G. Diab, G.M. Clark, C.K. Osborne Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas J Clin Oncol 17 1999 1442 1448
    • (1999) J Clin Oncol , vol.17 , pp. 1442-1448
    • Diab, S.G.1    Clark, G.M.2    Osborne, C.K.3
  • 8
    • 80053147913 scopus 로고    scopus 로고
    • Should liver metastases of breast cancer be biopsied to improve treatment choice?
    • G. Curigliano, V. Bagnardi, G. Viale Should liver metastases of breast cancer be biopsied to improve treatment choice? Ann Oncol 22 2011 2227 2233
    • (2011) Ann Oncol , vol.22 , pp. 2227-2233
    • Curigliano, G.1    Bagnardi, V.2    Viale, G.3
  • 9
    • 79960972539 scopus 로고    scopus 로고
    • Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer
    • S. van de Ven, V.T. Smit, T.J. Dekker Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer Cancer Treat Rev 37 2011 422 430
    • (2011) Cancer Treat Rev , vol.37 , pp. 422-430
    • Van De Ven, S.1    Smit, V.T.2    Dekker, T.J.3
  • 10
    • 0038607569 scopus 로고    scopus 로고
    • The role of cyclin-dependent kinase inhibitor p27Kip1 in anti-HER2 antibody-induced G1 cell cycle arrest and tumor growth inhibition
    • X.F. Le, F.X. Claret, A. Lammayot The role of cyclin-dependent kinase inhibitor p27Kip1 in anti-HER2 antibody-induced G1 cell cycle arrest and tumor growth inhibition J Biol Chem 278 2003 23441 23450
    • (2003) J Biol Chem , vol.278 , pp. 23441-23450
    • Le, X.F.1    Claret, F.X.2    Lammayot, A.3
  • 11
    • 3543146052 scopus 로고    scopus 로고
    • Monitoring of serum Her-2/neu predicts response and progression-free survival to trastuzumab-based treatment in patients with metastatic breast cancer
    • W.J. Köstler, B. Schwab, C.F. Singer Monitoring of serum Her-2/neu predicts response and progression-free survival to trastuzumab-based treatment in patients with metastatic breast cancer Clin Cancer Res 10 2004 1618 1624
    • (2004) Clin Cancer Res , vol.10 , pp. 1618-1624
    • Köstler, W.J.1    Schwab, B.2    Singer, C.F.3
  • 12
    • 0035915421 scopus 로고    scopus 로고
    • Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin)
    • Y. Lu, X. Zi, Y. Zhao Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin) J Natl Cancer Inst 93 2001 1852 1857
    • (2001) J Natl Cancer Inst , vol.93 , pp. 1852-1857
    • Lu, Y.1    Zi, X.2    Zhao, Y.3
  • 14
    • 0037142184 scopus 로고    scopus 로고
    • Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for Herceptin resistance
    • S.A. Price-Schiavi, S. Jepson, P. Li Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for Herceptin resistance Int J Cancer 99 2002 783 791
    • (2002) Int J Cancer , vol.99 , pp. 783-791
    • Price-Schiavi, S.A.1    Jepson, S.2    Li, P.3
  • 15
    • 12544250996 scopus 로고    scopus 로고
    • Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a Herceptin-resistant, MUC4-expressing breast cancer cell line
    • P. Nagy, E. Friedländer, M. Tanner Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a Herceptin-resistant, MUC4-expressing breast cancer cell line Cancer Res 65 2005 473 482
    • (2005) Cancer Res , vol.65 , pp. 473-482
    • Nagy, P.1    Friedländer, E.2    Tanner, M.3
  • 16
    • 0033135026 scopus 로고    scopus 로고
    • Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killer cells
    • M. Komatsu, L. Yee, K.L. Carraway Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killer cells Cancer Res 59 1999 2229 2236
    • (1999) Cancer Res , vol.59 , pp. 2229-2236
    • Komatsu, M.1    Yee, L.2    Carraway, K.L.3
  • 17
    • 0347123435 scopus 로고    scopus 로고
    • Mucins in cancer: Protection and control of the cell surface
    • M.A. Hollingsworth, B.J. Swanson Mucins in cancer: protection and control of the cell surface Nat Rev Cancer 4 2004 45 60
    • (2004) Nat Rev Cancer , vol.4 , pp. 45-60
    • Hollingsworth, M.A.1    Swanson, B.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.